BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  Athersys to Participate in The American Society for Neural Therapy and Repair Annual Conference

  Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications, announced today their participation in The American Society for Neural Therapy and Repair Annual Conference from April 27-30, 2023 in Clearwater, FL.

  April 21, 2023

   · 

  4 min read
• Policy

  FDA Roundup: April 21, 2023

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

  April 21, 2023

   · 

  4 min read
• Genetown

  Clinical Study of Over 1,000 Transplant Recipients Demonstrates Improved Clinical Outcomes in Heart Transplantation with the Paragonix SherpaPak

  Paragonix Technologies, Inc., a leading organ transplant company, announces that the latest clinical report of over 1,000 transplant patients studied in the GUARDIAN-Heart Registry was presented at the 2023 ISHLT Annual Meeting & Scientific Sessions.

  April 21, 2023

   · 

  6 min read
• Business

  GL CHEMTEC Announces Formation of Scientific Advisory Board

  GL CHEMTEC (“GLC”) today announced the formation of its Scientific Advisory Board comprised of distinguished leaders in Small Molecule R&D (Chemistry/Biology), Process Development & Scale-Up, Green Chemistry, Medical Devices and Drug Delivery.

  April 21, 2023

   · 

  6 min read
• Pharm Country

  Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 21, 2023

  Passage Bio, Inc., a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, announced it has granted an inducement award to a new employee.

  April 21, 2023

   · 

  2 min read
• FDA

  FDA Approves Medtronic MiniMed™ 780G System - World’s First Insulin Pump with Meal Detection Technology* Featuring 5-Minute Auto Corrections

  Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval of its MiniMed™ 780G system with the Guardian™ 4 sensor requiring no fingersticks while in SmartGuard™ technology.

  April 21, 2023

   · 

  6 min read